Medical Marijuana for Glaucoma in Arkansas: Everything You Need to Know

Disclaimer: This article is for educational purposes only and should not be considered medical advice. Consult your doctor before making any changes to your treatment plan.

Glaucoma is one of the leading causes of irreversible blindness worldwide, and Arkansas patients are increasingly exploring medical marijuana as part of their treatment plan.

While conventional medications can ease symptoms, more patients turn to supplements to reduce their reliance on pharmaceuticals when possible.

TeleLeaf connects Arkansas patients with licensed medical marijuana doctors who understand glaucoma and cannabis-based care. Call (504) 264-3123 today to book your appointment and explore your options.

What is Glaucoma?

Glaucoma is a group of eye diseases that damage the optic nerve, often linked to elevated intraocular pressure (IOP). Over time, untreated glaucoma can lead to vision loss and blindness.

The two most common types are:

• Open-angle glaucoma: The most common form, where eye drainage becomes less effective, gradually increasing IOP.
• Angle-closure glaucoma: A more sudden blockage in eye drainage, often requiring immediate medical attention.

Symptoms and Risks

Glaucoma can progress silently, with few early symptoms.

As the condition advances, you may notice:

• Loss of peripheral vision
• Eye pain or pressure
• Blurred vision
• Halos around lights

Risk factors include age, family history, high blood pressure, diabetes, and prolonged steroid use.

Medical Marijuana as a Potential Glaucoma Treatment

How Cannabis Works in the Eye

Cannabinoids in cannabis—especially THC—interact with the body’s endocannabinoid system (ECS), which regulates various functions, including IOP. Studies have shown that THC can temporarily lower IOP, which is beneficial for glaucoma patients.

Research from the National Eye Institute has documented IOP reduction lasting 3–4 hours after cannabis use. This short duration is why cannabis is often considered a supplemental therapy rather than a full replacement for traditional glaucoma medications.

Research on Cannabis for Glaucoma

Some key findings include:

• THC’s Effectiveness: THC appears to reduce IOP by about 25–30% in some patients.
• CBD’s Role: CBD does not lower IOP and, in high doses, may even increase it in some patients.
• Neuroprotection: Animal studies suggest cannabinoids may help protect retinal cells from damage.

But the short-lived effects mean multiple doses per day would be required to maintain IOP reduction, which may not be practical for all patients.

Arkansas Medical Marijuana Laws for Glaucoma Patients

Qualifying Conditions

Glaucoma is listed as a qualifying condition for medical marijuana in Arkansas. Patients must have a formal diagnosis from a licensed physician. You can review the official list of qualifying conditions on the Arkansas Department of Health’s website.

How to Get Approved

1. Get a Diagnosis – A licensed physician must confirm you have glaucoma.
2. Consult a Cannabis Doctor – TeleLeaf offers virtual consultations so you can meet with a certified Arkansas cannabis doctor from home.
3. Register with the State – Submit your application and physician’s certification to the Arkansas Department of Health, along with the application fee.
4. Receive Your Card – Once approved, you can purchase cannabis from licensed dispensaries.

Possession Limits

Arkansas patients may possess up to 2.5 ounces of usable cannabis every 14 days. It is illegal to grow your own cannabis at home. Keep all products stored safely and out of reach of children.

Suggested Cannabis Products for Glaucoma

THC vs. CBD

THC is the primary cannabinoid of interest for lowering IOP. CBD does not appear to have the same effect and may even counteract THC’s pressure-lowering benefits in high doses, but it can help with inflammation and anxiety.

Best Strains for Glaucoma

Patients often choose indica or indica-dominant hybrids for their relaxing effects and potential pain relief.

Popular strains:

• Northern Lights – Strong relaxation and potentially reduces IOP.
• Blueberry – Calming effects and pain relief.
• Granddaddy Purple – Sedative effects that may help with nighttime symptom management.

Consumption Methods

• Smoking/Vaping: Fastest onset (minutes), but effects last only a few hours.
• Edibles: Slower onset (30–90 minutes) but longer duration.
• Tinctures: Absorbed under the tongue, providing a balance between speed and duration.

Eye Drops: Research is ongoing; no FDA-approved cannabinoid eye drops are currently available.

Risks, Side Effects, and Considerations

Interactions with Other Medications

Cannabis can interact with certain prescription medications, including blood thinners and sedatives. Talk to your doctor about all medications you’re taking.

Limitations in Glaucoma Treatment

Cannabis reduces IOP only temporarily, generally for 3–4 hours, so it may require frequent dosing. It should not replace prescribed glaucoma treatments without the guidance of an ophthalmologist.

Tips for Safe and Effective Use

Start Low, Go Slow

Begin with the lowest effective dose and gradually adjust as needed. This approach minimizes side effects and helps you find the optimal balance for your symptoms.

Track Your Symptoms

Keep a journal of:

• Cannabis type and dose
• Time of administration
• IOP readings (if available)
• Side effects or changes in vision

Work with a Cannabis-Savvy Doctor

Regular follow-ups with a cannabis-trained physician ensure your treatment plan stays effective and safe. TeleLeaf doctors specialize in adjusting dosing and strain selection for glaucoma patients.

How to Register for an Arkansas Medical Marijuana Card

1. Register with TeleLeaf

2. Connect with a Doctor Online

   1. Connect with one of our licensed doctors to receive your legal recommendation.
   2. Register Online with the Arkansas State Medical Marijuana System Medical Marijuana ProgramPlease note you will need your completed physician-written certification from the doctor to complete this step in the process.

3. Print a Copy of Your Card

   Patients who apply online can print a copy of their cards after their applications are reviewed and approved. A physical card will be mailed automatically to you once your application has been approved. Processing time is up to 14 days from the date we receive your application and payment.

4. Get Access to Medicine

   Access medicine at any of the licensed state dispensaries using your card. A full list of Arkansas dispensaries can be found here.

Where to Buy Medical Marijuana in Arkansas

Licensed Dispensaries

Some Arkansas dispensaries known for medical-grade products include:

• The Source (Bentonville) – Wide selection of flowers and concentrates.
• Harvest House of Cannabis (Little Rock) — Known for patient education and high-quality strains.
• Natural Relief dispensaries (Sherwood) — Focus on wellness-oriented cannabis products.

What to Ask Your Budtender

When visiting a dispensaries, ask:

• Which strains are reported to help with eye pressure or pain?
• What’s the THC content and cannabinoid profile?

Are there products suitable for daytime vs. nighttime use?

The Future of Cannabis and Glaucoma Research

Current Clinical Trials

Ongoing studies are exploring:

• THC-based eye drops to target IOP directly.
• Cannabinoids that may offer neuroprotection without intoxicating effects.

Potential New Cannabinoids

Compounds like CBG (cannabigerol) and THCV (tetrahydrocannabivarin) are being studied for their potential roles in protecting optic nerve health and regulating eye pressure.

Take Control of Your Glaucoma Treatment

Medical marijuana offers Arkansas glaucoma patients a complementary option for managing eye pressure and related symptoms. While it isn’t a cure, it can be an important part of a broader care plan when used under medical supervision.

If you’re ready to explore medical cannabis for glaucoma, call TeleLeaf at (504) 264-3123 or visit our Arkansas medical marijuana page to schedule your consultation with a licensed cannabis physician. Our team will help you navigate Arkansas’ program and develop a personalized treatment strategy.